Trials / Unknown
UnknownNCT05339009
Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient
Bio-adrenomedullin (Bio-ADM) as a Biomarker of Refilling in Chronic Hemodialysis Patient
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BioADM determination in plasma | BioADM determination in plasma |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2022-12-31
- Completion
- 2023-05-01
- First posted
- 2022-04-21
- Last updated
- 2022-04-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05339009. Inclusion in this directory is not an endorsement.